» Articles » PMID: 14722525

Autosomal Recessive Hyperimmunoglobulin E Syndrome: a Distinct Disease Entity

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2004 Jan 15
PMID 14722525
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The autosomal-dominant form of the hyperimmunoglobulin E syndrome (AD-HIES) has been described as a multisystem disorder including immune, skeletal, and dental abnormalities. Variants of AD-HIES are known but not well defined.

Methods: We evaluated 13 human immunodeficiency virus-seronegative patients from six consanguineous families with an autosomal-recessive form of hyperimmunoglobulin E syndrome (AR-HIES) and 68 of their relatives.

Results: Persons affected with AR-HIES presented with the classical immunologic findings of hyperimmunoglobulin E syndrome, including recurrent staphylococcal infections of the skin and respiratory tract, eczema, elevated serum immunoglobulin E, and hypereosinophilia. In addition, severe recurrent fungal and viral infections with molluscum contagiosum, herpes zoster, and herpes simplex were noted. Autoimmunity was seen in two patients. Central nervous system sequelae, including hemiplegia, ischemic infarction, and subarachnoid hemorrhages, were common and contributed to high mortality. Notably, patients with AR-HIES did not have skeletal or dental abnormalities and did not develop pneumatoceles, as seen in AD-HIES. In lymphocyte proliferation assays, patients' cells responded poorly to mitogens and failed to proliferate in response to antigens, despite the presence of normal numbers of lymphocyte subpopulations.

Conclusion: The autosomal-recessive form of hyperimmunoglobulin E syndrome is a primary immunodeficiency with elevated immunoglobulin E, eosinophilia, vasculitis, autoimmunity, central nervous system symptoms, and high mortality. AR-HIES lacks several of the key findings of AD-HIES and therefore represents a different, previously unrecognized disease entity.

Citing Articles

Clinical and molecular profile of 20 patients with DOCK8 deficiency-a single-center experience from Southern India.

Singh N, Ranganath P, Jayaram A, Jhawar P, Kotecha U, Janardhanan J Immunol Res. 2024; 73(1):8.

PMID: 39666233 DOI: 10.1007/s12026-024-09571-9.


Challenges in diagnosing and managing hyper-IgE syndrome in a resource-limited setting: a case report.

Adhikari P, Regmi R, Yadav P, Kafle S Ann Med Surg (Lond). 2024; 86(9):5582-5585.

PMID: 39238996 PMC: 11374209. DOI: 10.1097/MS9.0000000000002407.


Autosomal Recessive Hyper-IgE Syndrome in a Child With Beta Thalassemia Trait: A Case Report.

Linganagouda S, Jadhav R, Verma S, Bharaswadkar R Cureus. 2024; 16(6):e61864.

PMID: 38978914 PMC: 11228417. DOI: 10.7759/cureus.61864.


A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families.

Guo M, Ma Y, Cai K, Liu X, Liu W, Wang F Immunogenetics. 2024; 76(3):165-173.

PMID: 38587548 DOI: 10.1007/s00251-024-01340-0.


Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis.

Kasap N, Kara A, Celik V, Bilgic Eltan S, Haci I, Kose H J Clin Immunol. 2023; 43(8):1882-1890.

PMID: 37507632 DOI: 10.1007/s10875-023-01554-z.